News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
557,862 Results
Type
Article (40287)
Company Profile (167)
Press Release (517408)
Section
Business (160136)
Career Advice (2429)
Deals (28912)
Drug Delivery (82)
Drug Development (74693)
Employer Resources (141)
FDA (13619)
Job Trends (12736)
News (282494)
Policy (27525)
Tag
Academia (2554)
Africa (745)
Alliances (40686)
Alzheimer's disease (1184)
Antibody-drug conjugate (ADC) (58)
Approvals (13550)
Arizona (102)
Artificial intelligence (69)
Asia (34576)
Australia (7025)
Bankruptcy (304)
Best Places to Work (10108)
Biotechnology (143)
Breast cancer (61)
C2C Services and Suppliers (54456)
California (1799)
Canada (889)
Cancer (545)
Career advice (2041)
Cell therapy (132)
China (145)
Clinical research (58538)
Collaboration (155)
Colorado (69)
Connecticut (71)
COVID-19 (2424)
Cystic fibrosis (68)
Data (412)
Diabetes (86)
Diagnostics (5453)
Drug pricing (69)
Earnings (55224)
Employer resources (126)
Europe (76758)
Events (80212)
Executive appointments (169)
FDA (13876)
Florida (261)
Funding (156)
Gene therapy (98)
GLP-1 (512)
Government (4059)
Healthcare (16186)
Hotbed/Location (371741)
Illinois (247)
Indiana (145)
Infectious disease (2458)
Inflammatory bowel disease (93)
Interviews (515)
IPO (12927)
Job creations (2797)
Job search strategy (1690)
Kansas (84)
Layoffs (365)
Legal (5845)
Lung cancer (123)
Manufacturing (88)
Maryland (386)
Massachusetts (1313)
Medical device (10411)
Medtech (10415)
Mergers & acquisitions (15894)
Metabolic disorders (260)
Michigan (114)
Minnesota (189)
Neuroscience (1366)
New Jersey (538)
New York (567)
NextGen Class of 2024 (5670)
Non-profit (4005)
North Carolina (531)
Northern California (795)
Obesity (151)
Ohio (93)
Opinion (182)
Patents (78)
Pennsylvania (491)
People (51820)
Phase I (18128)
Phase II (25795)
Phase III (19486)
Pipeline (121)
Policy (59)
Postmarket research (2322)
Preclinical (7490)
Press Release (65)
Radiopharmaceuticals (208)
Rare diseases (141)
Real estate (4595)
Regulatory (18575)
Research institute (2169)
Resumes & cover letters (356)
South America (1033)
Southern California (762)
Startups (3006)
Texas (232)
United States (7811)
Vaccines (447)
Washington State (241)
Weight loss (134)
Date
Last 7 days (531)
Last 30 days (2244)
Last 365 days (33384)
2024 (24407)
2023 (35748)
2022 (46410)
2021 (49889)
2020 (48050)
2019 (41006)
2018 (31079)
2017 (28227)
2016 (27012)
2015 (31460)
2014 (23955)
2013 (19527)
2012 (20906)
2011 (21902)
2010 (19580)
557,862 Results for "chrysalis biotherapeutics formerly known as chrysalis biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lone Star Bio
Chrysalis BioTherapeutics Selected to Present at Respiratory Innovation Summit
Chrysalis BioTherapeutics today announced it was selected to participate in the 2024 Respiratory Innovation Summit (RIS) at the American Thoracic Society Meeting in San Diego.
May 6, 2024
·
2 min read
Drug Development
Chrysalis Receives FDA Approval to Initiate Clinical Trials with Chrysalin™ (TP508)
Chrysalis BioTherapeutics, Inc. announced today that the US Food and Drug Administration (FDA) has given the company permission to initiate human clinical trials aimed at treating acute lung failure.
September 26, 2023
·
2 min read
TILT Biotherapeutics Presents Clinical Data on TILT-123 in Ovarian Cancer at ASCO 2024
TILT Biotherapeutics, a clinical-stage biotechnology company developing cancer immunotherapies, announces that it will present two abstracts at the American Society of Clinical Oncology Annual Meeting 2024.
May 28, 2024
·
4 min read
BioMidwest
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
Baxter International Inc. announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis.
May 29, 2024
·
5 min read
Biotech Beach
Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting
Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the presentation of three abstracts in a poster session during the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.
June 3, 2024
·
7 min read
Business
Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference
September 10, 2024
·
3 min read
Press Releases
Adolore BioTherapeutics to Present at BioSparkVA Pitch Event
September 25, 2024
·
3 min read
Biotech Bay
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting
Iovance Biotherapeutics, Inc. announced updated clinical data for lifileucel in combination with pembrolizumab in frontline advanced melanoma, as well as translational data, for the upcoming 2024 ASCO Annual Meeting to be held May 31 – June 4, 2024, at McCormick Place in Chicago, IL and online.
May 23, 2024
·
10 min read
Biotech Bay
Iovance Biotherapeutics to Present at Upcoming Conferences and Events - May 24, 2024
Iovance Biotherapeutics, Inc., a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte therapies for patients with cancer, announced that senior leadership plans to present at the following conferences and events.
May 24, 2024
·
6 min read
BioMidwest
Anbio Biotechnology to Showcase at ADLM 2024 with Evolved In Vitro Diagnostic Solutions
Anbio Biotechnology (“Anbio”), a leading global diagnostic solution provider, is excited to announce its participation in the ADLM 2024 Clinical Lab Expo (formerly the AACC Clinical Lab Expo).
July 1, 2024
·
1 min read
1 of 55,787
Next
